Drug Trial Radar · NCT02901288
Shortened Regimens for Drug-susceptible Pulmonary Tuberculosis
Last checked: Nov 19, 2026Latest source record: Mar 20, 2017 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Status unknown
Enrollment
3,900
Planned (sponsor's estimate)
Start
Aug 2016
Primary completion
Dec 2018
Study completion Dec 2018
Sponsor
- Lead sponsor
- Beijing Chest HospitalAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- Collaborators
- Hubei Provincial Center for Disease Control and Prevention; Centre for Tuberculosis Control of Guangdong Province; Hunan Institute For Tuberculosis Control; Anhui Chest Hospital; Guangxi Zhuang Autonomous Region Center for Disease Prevention and Control; Wuhan Institute for Tuberculosis Control; Shanghai Pulmonary Hospital, Shanghai, China; Shenyang Chest Hospital; Changchun Infectious Disease Hospital; First Affiliated Hospital of Xinjiang Medical University; Chengdu Public Health Clinical Center; Taiyuan Fourth People's Hospital; The Sixth People's Hospital of Nantong; The Tuberculosis Prevention and Treatment Hospital of Shanxi Province; Beijing Research Institute for Tuberculosis Control; Infectious Disease Prevention Hospital in Heilongjiang Province; The Third People's Hospital of Zhenjiang; Tianjin centers for Disease Control and Prevention; Harbin Chest Hospital; Chest of Hospital of Xinjiang Uygur Autonomous Region of the PRC; Heilongjiang Province center for tuberculosis Control and Prevention; Tianjin Haihe Hospital; The Infectious Disease Hospital of Wangkai Zaozhuang; The Third People's Hospital of Kunming City; Kaifeng Central Hospital; The Infectious Hospital of Hebi; Pulmonary Hospital of Lanzhou; The Fourth People's Hospital of Ningxia Autonomous Region; The Fourth People's Hospital of Qinghai Province; The Fifth People's Hospital of Suzhou; Chongqing Infectious Disease Medical Center; Tuberculosis Hospital in Jilin Province; Sixth People's Hospital of Nanyang City; Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
- First posted
- Sep 15, 2016
Design
- Study type
- Interventional
- Phase
- Phase 4
- Allocation
- Randomized
- Model
- Parallel
- Masking
- None
- Primary purpose
- Treatment
- Who can join
- All sexes, from 18 years, up to 65 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of the study is to evaluate the safety and efficacy of two shortened regimens for newly diagnosed smear positive drug susceptible pulmonary tuberculosis in comparison to World Health Organization recommended standard 6-month regimen.
Conditions
- Tuberculosis, Pulmonary
Interventions
IsoniazidDrug
Isoniazid is a widely used anti-tuberculosis medication. Its primary action is to inhibit the synthesis of long-chain mycolic acids, which are unique components of mycobacterial cell wall.
RifampicinDrug
Rifampicin is a widely used anti-tuberculosis medication.
PyrazinamideDrug
Pyrazinamide is a commonly used medication for tuberculosis, with bactericidal effect against intracellular mycobacterium tuberculosis.
EthambutolDrug
Ethambutol is a widely used medicine in anti-TB regimens with bacteriostatic effect against M. tb.
LevofloxacinDrug
Levofloxacin is a commonly used antimicrobial for TB and other infections, which acts on the DNA-DNA-gyrase complex and topoisomerase IV. It is the S (-) enantiomer of the racemic active substance ofloxacin.
Primary outcomes
What the sponsor says the trial is designed to measure.
- The percentage of participants with TB recurrence/relapse by 24 months after the end of treatment.Time frame: 24 months after treatment completion for all 3 groups
- Percentage of participants with treatment failure at either 4.5 months or 6 months after randomization.Time frame: 4.5 months after randomization for experimental group1 and 2; 6 months after randomization for control group
Locations
35 sites in 1 country. Site status is shown where the registry gives one.
Anhui Chest Hospital
Hefei, Anhui, China · Recruiting
Beijing Research Institute for Tuberculosis Control
Beijing, Beijing Municipality, China · Recruiting
Beijing Chest Hospital,Capital Meical University
Beijing, Beijing Municipality, China · Recruiting
Chongqing Infectious Disease Medical Center
Chongqing, Chongqing Municipality, China · Recruiting
Pulmonary Hospital of Lanzhou
Lanzhou, Gansu, China · Recruiting
Centre for Tuberculosis Control of Guangdong Province
Guangzhou, Guangdong, China · Recruiting
Guangxi Center for Disease Prevention and Control
Nanning, Guangxi, China · Recruiting
HeBei Province Center for Disease Prevention and Control
Shijiazhuang, Hebei, China · Recruiting
Heilongjiang Province center for tuberculosis Control and Prevention
Haerbin, Heilongjiang, China · Recruiting
Harbin Chest Hospital
Harbin, Heilongjiang, China · Recruiting
Infectious Disease Prevention Hospital in Heilongjiang Province
Harbin, Heilongjiang, China · Recruiting
The Infectious Hospital of Hebi
Hebi, Henan, China · Recruiting
Kaifeng Pulmonary Disease Hospital
Kaifeng, Henan, China · Recruiting
Sixth People's Hospital of Nanyang City
Nanyang, Henan, China · Recruiting
The First Affiliated Hospital of Xinxiang Medical University
Xianxiang, Henan, China · Recruiting
Wuhan medical treatment center
Wuhan, Hubei, China · Recruiting
Wuhan Institute For Tuberculosis Control
Wuhan, Hubei, China · Recruiting
Hunan Institute For Tuberculosis Control
Changsha, Hunan, China · Recruiting
The Sixth People's Hospital of Nantong
Nantong, Jiangsu, China · Recruiting
The Fifth People's Hospital of Suzhou
Suzhou, Jiangsu, China · Recruiting
The Third People's Hospital of Zenjiang
Zhenjiang, Jiangsu, China · Recruiting
Changchun Infectious Disease Hospital
Changchun, Jilin, China · Recruiting
Tuberculosis Hospital in Jilin Province
Jilin City, Jilin, China · Recruiting
China Shenyang Chest Hospital
Shenyang, Jilin, China · Recruiting
The Fourth People's Hospital of Ningxia Autonomous Region
Yinchuan, Ningxia, China · Recruiting
The 4th People's Hospital of Qinghai Province
Xining, Qinghai, China · Recruiting
The Infectious Disease Hospital of Wangkai Zaozhuang
Tengzhou, Shandong, China · Recruiting
Shanghai Pulmonary Hospital
Shanghai, Shanghai Municipality, China · Recruiting
Taiyuan Fourth People's Hospital
Taiyuan, Shanxi, China · Recruiting
The Tuberculosis Prevention and Treatment Hospital of Shanxi Province
Xi’an, Shanxi, China · Recruiting
Public Health Clinical Center of Chengdu
Chengdu, Sichuan, China · Recruiting
Tianjin Haihe Hospital
Tianjin, Tianjin Municipality, China · Recruiting
Tianjin centers for Disease Control and Prevention
Tianjin, Tianjin Municipality, China · Recruiting
Chest of Hospital of Xinjiang Uygur Autonomous Region of the PRC
Ürümqi, Xinjiang, China · Recruiting
The Third People's Hospital of Kunming City
Kunming, Yunnan, China · Recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.